Clinical Trials Directory

Trials / Completed

CompletedNCT00800540

Circadian Ocular Perfusion Pressure and Ocular Blood Flow

Effects of Topical Hypotensive Drugs on Circadian Ocular Perfusion Pressure and Ocular Blood Flow in Patients With Open-Angle Glaucoma

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to compare the short term effects of two intraocular pressure (IOP) lowering medications on ocular perfusion pressure (OPP), ocular blood flow, intraocular pressure, and blood pressure in patients with glaucoma. Ocular perfusion pressure (OPP) is defined as the difference between arterial blood pressure (diastolic and systolic) and intraocular pressure. The primary efficacy assessment is based on diastolic ocular perfusion pressure.

Conditions

Interventions

TypeNameDescription
DRUGBrinzolamide 10 mg/ml/Timolol 5 mg/ml eye drops suspensionFixed combination ophthalmic suspension
DRUGBrimonidine 20 mg/ml/Timolol 5 mg/ml eye drops solutionFixed combination ophthalmic solution

Timeline

Start date
2009-02-01
Primary completion
2012-01-01
Completion
2012-01-01
First posted
2008-12-02
Last updated
2013-03-22
Results posted
2013-03-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00800540. Inclusion in this directory is not an endorsement.